These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 31536806

  • 1. Menopausal Hormone Therapy and Risks of First Hospitalized Heart Failure and its Subtypes During the Intervention and Extended Postintervention Follow-up of the Women's Health Initiative Randomized Trials.
    Liu L, Klein L, Eaton C, Panjrath G, Martin LW, Chae CU, Greenland P, Lloyd-Jones DM, Wactawski-Wende J, Manson JE.
    J Card Fail; 2020 Jan; 26(1):2-12. PubMed ID: 31536806
    [Abstract] [Full Text] [Related]

  • 2. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
    Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O'Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB.
    JAMA; 2013 Oct 02; 310(13):1353-68. PubMed ID: 24084921
    [Abstract] [Full Text] [Related]

  • 3. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
    Chlebowski RT, Anderson GL, Aragaki AK, Manson JE, Stefanick ML, Pan K, Barrington W, Kuller LH, Simon MS, Lane D, Johnson KC, Rohan TE, Gass MLS, Cauley JA, Paskett ED, Sattari M, Prentice RL.
    JAMA; 2020 Jul 28; 324(4):369-380. PubMed ID: 32721007
    [Abstract] [Full Text] [Related]

  • 4. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.
    Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thomson CA, Margolis KL, Lewis CE, Stefanick ML, Jackson RD, Johnson KC, Martin LW, Shumaker SA, Espeland MA, Wactawski-Wende J, WHI Investigators.
    JAMA; 2017 Sep 12; 318(10):927-938. PubMed ID: 28898378
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH, Women's Health Initiative Memory Study.
    JAMA; 2004 Jun 23; 291(24):2947-58. PubMed ID: 15213206
    [Abstract] [Full Text] [Related]

  • 7. Metabolomic Effects of Hormone Therapy and Associations With Coronary Heart Disease Among Postmenopausal Women.
    Balasubramanian R, Demler O, Guasch-Ferré M, Paynter NP, Sheehan R, Liu S, Manson JE, Salas-Salvadó J, Martínez-Gonzalez MÁ, Hu FB, Clish C, Rexrode KM.
    Circ Genom Precis Med; 2020 Dec 23; 13(6):e002977. PubMed ID: 33141616
    [Abstract] [Full Text] [Related]

  • 8. Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials.
    Maalouf NM, Sato AH, Welch BJ, Howard BV, Cochrane BB, Sakhaee K, Robbins JA.
    Arch Intern Med; 2010 Oct 11; 170(18):1678-85. PubMed ID: 20937929
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
    Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML, WHI Investigators.
    JAMA; 2008 Mar 05; 299(9):1036-45. PubMed ID: 18319414
    [Abstract] [Full Text] [Related]

  • 11. The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.
    Manson JE, Bassuk SS, Kaunitz AM, Pinkerton JV.
    Menopause; 2020 Aug 05; 27(8):918-928. PubMed ID: 32345788
    [Abstract] [Full Text] [Related]

  • 12. Hormone Therapy Use and Risk of Chronic Disease in the Nurses' Health Study: A Comparative Analysis With the Women's Health Initiative.
    Bhupathiraju SN, Grodstein F, Rosner BA, Stampfer MJ, Hu FB, Willett WC, Manson JE.
    Am J Epidemiol; 2017 Sep 15; 186(6):696-708. PubMed ID: 28938710
    [Abstract] [Full Text] [Related]

  • 13. Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.
    Chlebowski RT, Rohan TE, Manson JE, Aragaki AK, Kaunitz A, Stefanick ML, Simon MS, Johnson KC, Wactawski-Wende J, O'Sullivan MJ, Adams-Campbell LL, Nassir R, Lessin LS, Prentice RL.
    JAMA Oncol; 2015 Jun 15; 1(3):296-305. PubMed ID: 26181174
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.
    Chlebowski RT, Anderson GL, Sarto GE, Haque R, Runowicz CD, Aragaki AK, Thomson CA, Howard BV, Wactawski-Wende J, Chen C, Rohan TE, Simon MS, Reed SD, Manson JE.
    J Natl Cancer Inst; 2016 Mar 15; 108(3):. PubMed ID: 26668177
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials.
    Jiang X, Aragaki AK, Nudy M, Manson JE, Shadyab AH, Wild RA, Valdiviezo C, Gass M, Martin LW, Pan K, Stefanick ML, Robbins JA, Schnatz PF.
    Menopause; 2023 Jan 01; 30(1):28-36. PubMed ID: 36256926
    [Abstract] [Full Text] [Related]

  • 18. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.
    LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL, Stefanick ML, Brzyski R, Curb JD, Howard BV, Lewis CE, Wactawski-Wende J, WHI Investigators.
    JAMA; 2011 Apr 06; 305(13):1305-14. PubMed ID: 21467283
    [Abstract] [Full Text] [Related]

  • 19. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
    Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J, Women's Health Initiative Memory Study.
    JAMA; 2004 Jun 23; 291(24):2959-68. PubMed ID: 15213207
    [Abstract] [Full Text] [Related]

  • 20. No Increase in Fractures After Stopping Hormone Therapy: Results From the Women's Health Initiative.
    Watts NB, Cauley JA, Jackson RD, LaCroix AZ, Lewis CE, Manson JE, Neuner JM, Phillips LS, Stefanick ML, Wactawski-Wende J, Crandall C, Women’s Health Initiative Investigators.
    J Clin Endocrinol Metab; 2017 Jan 01; 102(1):302-308. PubMed ID: 27820659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.